HPV vaccines are reducing fertility

Menopausal FSH levels in young female recipients of GARDASIL/GARDASIL9

Nov 19, 2022

Summary

I took a look into the LAB_DATA field of VAERS entries in adverse event for both the HPV vaccines and all other vaccines.

Among HPV vaccine reports there were 9 entries about women aged 12-25 which had the LAB_DATA field populated with the results of follicle-stimulating hormone levels tests.

Of these 9 entries 8 had menopausal FSH levels and 1 had a level of 0.8 IU/l.

The average FSH level in female HPV vaccinees aged 12-25 was 72.4 ±23.3 IU/l (95% CI: 49.2 – 95.7 IU/l) which is physiological only in post-menopausal women.

In comparison the average FSH level in females aged 15-34 who received another vaccine was 13.7 ±8.1 IU/l (95% CI: 5.6 – 21.8 IU/l).

EDIT: All patients who had elevated FSH levels took GARDASIL or GARDASIL9. The only patient with physiological FSH levels took CERVARIX.

Introduction

I stumbled over a publication from 2017 which states: “Approximately 60% of women who did not receive the HPV vaccine had been pregnant at least once, whereas only 35% of women who were exposed to the vaccine had conceived. […] If 100% of females in this study had received the HPV vaccine, data suggest the number of women having ever conceived would have fallen by 2 million [in the USA].”

This stimulated me to browse VAERS for all reports which LAB_DATA field contain FSH level test results.

Methods

I searched all VAERS reports for entries which LAB_DATA field matched the following Regular Expression:

/(^FSH\W)|(\WFSH\W)|(\WFSH$)/

It would have made sense to look for LH, estradiol and AMH levels as well, but time is a precious resource and there are lots of other peculiarities in the VAERS database that I would like to write about, so FSH will have to do for today.

I have plotted all the lab results to a scatter chart against patient age for both vaccinees receiving a HPV vaccine and vaccinees receiving another vaccine.